» Articles » PMID: 25257250

EGFR Signaling Patterns Are Regulated by Its Different Ligands

Overview
Journal Growth Factors
Publisher Informa Healthcare
Specialty Biology
Date 2014 Sep 27
PMID 25257250
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

EGF receptor (EGFR) and its signaling have been investigated for many years, but how its different ligands regulate signaling has not been thoroughly explored. When investigating EGFR activation and downstream signaling in HeLa cells using a panel of ligands, we found a ligand-dependent differential activation of EGFR and the signaling pathways Akt, PLCγ and STAT with HB-EGF and BTC being the most potent ligands. All the tested ligands induced full activation of Erk signaling at 1 nM, whereas only HB-EGF and partly BTC and EGF induced strong activation of Akt, STAT3 and PLCγ at this concentration. Interestingly, we also found that the high activation potencies of HB-EGF and BTC could only partially be explained by their binding affinities, and are therefore likely to be regulated by other mechanisms. We thus suggest that the signaling pathways initiated from the EGFR vary depending on the ligands bound in a cell specific manner.

Citing Articles

Cell Adhesion Molecules as Modulators of the Epidermal Growth Factor Receptor.

Kozlova I, Sytnyk V Cells. 2024; 13(22).

PMID: 39594667 PMC: 11592701. DOI: 10.3390/cells13221919.


Epidermal growth factor receptor inhibition potentiates chemotherapeutics-mediated sensitization of metastatic breast cancer stem cells.

Kar T, Dugam P, Shivhare S, Shetty S, Choudhury S, Sen D Cancer Rep (Hoboken). 2024; 7(3):e2049.

PMID: 38522013 PMC: 10961089. DOI: 10.1002/cnr2.2049.


EGFR signaling and pharmacology in oncology revealed with innovative BRET-based biosensors.

Gross F, Mancini A, Breton B, Kobayashi H, Pereira P, Le Gouill C Commun Biol. 2024; 7(1):250.

PMID: 38429428 PMC: 10907714. DOI: 10.1038/s42003-024-05965-5.


Does EGFR Signaling Mediate Orexin System Activity in Sleep Initiation?.

Kniazkina M, Dyachuk V Int J Mol Sci. 2023; 24(11).

PMID: 37298454 PMC: 10253995. DOI: 10.3390/ijms24119505.


Biased activation of the receptor tyrosine kinase HER2.

Catapano C, Rahm J, Omer M, Teodori L, Kjems J, Dietz M Cell Mol Life Sci. 2023; 80(6):158.

PMID: 37208479 PMC: 10198881. DOI: 10.1007/s00018-023-04806-8.